• Naprawa, J.T., Bonsu, B.K., Goodman, D.G. & Ranalli, M.A. (2005) Serum biomarkers for identifying acute chest syndrome among patients who have sickle cell disease and present to the emergency department. Pediatrics, 116, e420e425.
  • Partrick, D.A., Moore, E.E., Silliman, C.C., Barnett, C.C. & Kuypers, F.A. (2001) Secretory phospholipase A2 activity correlates with postinjury multiple organ failure. Critical Care Medicine, 29, 989993.
  • Styles, L.A., Schalkwijk, C.G., Aarsman, A.J., Vichinsky, E.P., Lubin, B.H. & Kuypers, F.A. (1996) Phospholipase A2 levels in acute chest syndrome of sickle cell disease. Blood, 87, 25732578.
  • Styles, L.A., Aarsman, A.J., Vichinsky, E.P. & Kuypers, F.A. (2000) Secretory phospholipase A(2) predicts impending acute chest syndrome in sickle cell disease. Blood, 96, 32763278.
  • Vichinsky, E.P., Styles, L.A., Colangelo, L.H., Wright, E.C., Castro, O. & Nickerson, B. (1997) Acute chest syndrome in sickle cell disease: clinical presentation and course. Cooperative Study of Sickle Cell Disease. Blood, 89, 17871792.
  • Vichinsky, E., Neumayr, L., Earles, A., Williams, H., Lennette, E., Dean, D., Nickerson, B., Orringer, E., McKie, V., Bellevue, R., Daeschner, C. & Manci, E. (2000) Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. New England Journal of Medicine, 342, 18551865.